Economic Evaluation of the MENTOR Trial Comparing Rituximab and Cyclosporine for the Treatment of Membranous Nephropathy (MN)
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 32 | Issue: 10S | Pages: 515-515
10.1681/asn.20213210s1515b